Ailing Sui

439 total citations
13 papers, 340 citations indexed

About

Ailing Sui is a scholar working on Ophthalmology, Immunology and Molecular Biology. According to data from OpenAlex, Ailing Sui has authored 13 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Ophthalmology, 8 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Ailing Sui's work include Retinal Diseases and Treatments (9 papers), Immune cells in cancer (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Ailing Sui is often cited by papers focused on Retinal Diseases and Treatments (9 papers), Immune cells in cancer (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Ailing Sui collaborates with scholars based in China and United States. Ailing Sui's co-authors include Yanji Zhu, Xi Shen, Bing Xie, Yujuan Cai, Anna M. Demetriades, Yushuo Gao, Yiyun Yao, Qing Lü, Jikui Shen and Ting Su and has published in prestigious journals such as Scientific Reports, Investigative Ophthalmology & Visual Science and Cell Death and Disease.

In The Last Decade

Ailing Sui

13 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ailing Sui China 11 148 148 123 63 56 13 340
Lishi Su China 12 208 1.4× 167 1.1× 108 0.9× 64 1.0× 37 0.7× 16 436
Anna M. Demetriades United States 13 210 1.4× 276 1.9× 67 0.5× 152 2.4× 32 0.6× 21 463
Svetlana Navitskaya United States 9 228 1.5× 133 0.9× 59 0.5× 32 0.5× 53 0.9× 11 339
Seth D. Fortmann United States 12 155 1.0× 155 1.0× 38 0.3× 85 1.3× 18 0.3× 28 390
Armin Farahvash Canada 9 98 0.7× 80 0.5× 154 1.3× 65 1.0× 12 0.2× 20 343
Caiyun You China 11 66 0.4× 198 1.3× 37 0.3× 81 1.3× 11 0.2× 28 355
Georg Mossböck Austria 14 105 0.7× 393 2.7× 27 0.2× 193 3.1× 24 0.4× 29 477
Yun‐Hsiang Chang Taiwan 12 66 0.4× 197 1.3× 33 0.3× 132 2.1× 9 0.2× 23 324
Pierfrancesco Mirabelli Sweden 9 102 0.7× 73 0.5× 33 0.3× 111 1.8× 8 0.1× 16 312

Countries citing papers authored by Ailing Sui

Since Specialization
Citations

This map shows the geographic impact of Ailing Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailing Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailing Sui more than expected).

Fields of papers citing papers by Ailing Sui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ailing Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailing Sui. The network helps show where Ailing Sui may publish in the future.

Co-authorship network of co-authors of Ailing Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Ailing Sui. A scholar is included among the top collaborators of Ailing Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ailing Sui. Ailing Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
3.
Cai, Yujuan, Ailing Sui, Yiyun Yao, et al.. (2020). Etanercept as a TNF-alpha inhibitor depresses experimental retinal neovascularization. Graefe s Archive for Clinical and Experimental Ophthalmology. 259(3). 661–671. 16 indexed citations
5.
Sui, Ailing, Xiuping Chen, Anna M. Demetriades, et al.. (2020). Inhibiting NF-κB Signaling Activation Reduces Retinal Neovascularization by Promoting a Polarization Shift in Macrophages. Investigative Ophthalmology & Visual Science. 61(6). 4–4. 35 indexed citations
7.
Sui, Ailing, Yisheng Zhong, Anna M. Demetriades, et al.. (2018). Inhibition of integrin α5β1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model. Graefe s Archive for Clinical and Experimental Ophthalmology. 256(5). 951–961. 19 indexed citations
8.
Su, Ting, Yisheng Zhong, Anna M. Demetriades, et al.. (2018). Endocan Blockade Suppresses Experimental Ocular Neovascularization in Mice. Investigative Ophthalmology & Visual Science. 59(2). 930–930. 16 indexed citations
9.
Sui, Ailing, Yisheng Zhong, Anna M. Demetriades, et al.. (2018). ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis. Medical Science Monitor. 24. 5860–5873. 16 indexed citations
11.
Zhu, Yanji, Ling Zhang, Qing Lü, et al.. (2017). Identification of different macrophage subpopulations with distinct activities in a mouse model of oxygen-induced retinopathy. International Journal of Molecular Medicine. 40(2). 281–292. 50 indexed citations
12.
Cai, Yujuan, Wei Tan, Xi Shen, et al.. (2016). Neutralization of IL-23 depresses experimental ocular neovascularization. Experimental Eye Research. 146. 242–251. 16 indexed citations
13.
Zhu, Yanji, Wei Tan, Anna M. Demetriades, et al.. (2015). Interleukin‐17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization. Immunology. 147(4). 414–428. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026